FDA Approved: SINUVA — Supplemental Application (Intersect ENT, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SINUVA (mometasone furoate) from Intersect ENT, Inc., updating its label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• SINUVA (Mometasone furoate)

Snippet

SUPPL AP for SINUVA (MOMETASONE FUROATE)